WESTBOROUGH, Mass., June 23 /PRNewswire/ -- IBC Life Sciences' 9th Annual Drug Discovery Technology(R) World Congress, to be held August 8-13, 2004 in Boston, Massachusetts will include 5 in-depth symposia that will cover the latest advances in drug discovery. The conference provides attendees with opportunities to learn about these key developments and interact with fellow attendees in complementary disciplines.
Each track will cover the latest topics in drug discovery. 160 speakers will present in the following sessions:
* Advances in Drug Discovery Symposium will cover proven scientific
strategies and promising techniques that will accelerate drug
discovery efforts to expand the drug pipeline.
* Discovery to Clinic Symposium will present a look at the innovative
strategies and technologies that are being employed for improving
success rates as compounds transition from the discovery phase to
early clinical development.
* Advances in Biotherapeutic Discovery Symposium will cover the
opportunities that exist in the biotherapeutic market and the
scientific research advances that are driving the discovery of these
new, promising protein therapeutics.
* Business Strategy & Partnering Symposium will provide case studies
about alliances and partnering agreements in efforts to raise
production and revenue.
* Discovery Informatics Symposium will present strategies that companies
are successfully employing to integrate biological, chemistry and
other information at the scientific level.
In addition to the extensive programming, Drug Discovery Technology(R) will cover the latest advances in new technology. There will be more than 400 booths in the exhibit hall that will showcase the latest products and services. In addition, more than 90 companies have indicated that they will be launching a new product at this year's event. Technology workshops, product demonstrations and panel discussions will also offer attendees the opportunity to learn about the new technology in drug discovery.
"Drug Discovery Technology(R) World Congress has provided a comprehensive mix of content to all individuals involved in the drug discovery process for the past nine years," said Kirstie Miller, President, IBC USA Conferences. "Attendees have had the opportunity to benefit from all this event has to offer ... up-to-date information, extensive network opportunities and the chance to learn about new technology."
This event is designed to attract an audience of pharmaceutical, biotechnology, government and academic researchers, executives and technology providers in the drug discovery arena with topics covering the science, business and informatics issues involved in drug discovery and R&D in general. The Drug Discovery Technology(R) World Congress expects over 6,000 attendees to participate.
"Drug Discovery Technology(R) offers attendees an informative view of the new trends in drug discovery," said past attendee, Pierre Beauparlant, GeminX.
For more information about Drug Discovery Technology(R) 2004, visit http://www.drugdisc.com/
About IBC Life Sciences 9th Annual Drug Discovery Technology(R) World Congress The Drug Discovery Technology(R) World Congress is designed for drug discovery researchers and business executives to evaluate and understand the latest advances in drug discovery research. In addition to a full conference program of speakers and keynotes, this event features an exhibit hall of 400+ exhibit booths showcasing the newest technologies and products that are driving the drug discovery field.
Leaders from pharmaceutical and biotechnology companies as well as academic and government research laboratories come to this event to learn the latest scientific advances in the drug discovery process, to learn about partnering, deal-making and negotiation/valuation, as well as to understand how informatics is transforming drug discovery.
Drug Discovery Technology(R) 2004 will be held August 8-13, 2004 at The Hynes Convention Center in Boston, Massachusetts. More information can be found at: http://www.drugdisc.com/
About IBC Life Sciences
IBC Life Sciences is an independent organizer that is in business to provide an unbiased forum for the evaluation of current research, market trends, technological developments and applications. IBC Life Sciences is part of IBC USA Conferences, Inc., part of The Informa Group plc (LONDON: INF) . The Informa Group has been a publisher and event organizer in the life sciences industry for over 20 years.
IBC also organizes major international activities in mainland Europe, Central & Eastern Europe, the former Soviet Union, Central Asia, the Middle and Far East, North and South America and North and South Africa. IBC USA Conferences is headquartered in Westborough, Massachusetts.
For more information: IBC Life Sciences Ellen Massa Senior Marketing Manager Telephone: (508) 616-5550 E-mail: emassa@ibcusa.comhttp://www.drugdisc.com/
IBC Life SciencesCONTACT: Ellen Massa, Senior Marketing Manager of IBC Life Sciences, +1-508-616-5550, emassa@ibcusa.com